Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 155 participants.

Also called NCT01589653

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 155 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01589653
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Egypt, Indonesia, Morocco, Saudi Arabia, Tunisia, Vietnam (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01589653. Randomized; no masking; primary purpose treatment. Start 2012-05-26 (actual); primary completion 2015-07-09 (actual). Results posted on 2016-08-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
biphasic insulin aspart 30
Intervention (Drug)
biphasic insulin aspart 30
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01589653
Content hash
f54c896db59071ff12d03cd3981820c99bebd1a32ef315ba94491f69cbbb4dd5